200 related articles for article (PubMed ID: 23106462)
1. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Elliott J
Am J Vet Res; 2012 Nov; 73(11):1765-74. PubMed ID: 23106462
[TBL] [Abstract][Full Text] [Related]
2. Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease.
Hezzell MJ; Falk T; Olsen LH; Boswood A; Elliott J
J Vet Cardiol; 2014 Dec; 16(4):257-64. PubMed ID: 25292459
[TBL] [Abstract][Full Text] [Related]
3. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
4. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
Galizzi A; Bagardi M; Stranieri A; Zanaboni AM; Malchiodi D; Borromeo V; Brambilla PG; Locatelli C
BMC Vet Res; 2021 Jan; 17(1):15. PubMed ID: 33413406
[TBL] [Abstract][Full Text] [Related]
6. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
7. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
Mangklabruks T; Surachetpong SD
J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
[TBL] [Abstract][Full Text] [Related]
9. The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease.
Höglund K; Häggström J; Höglund OV; Stridsberg M; Tidholm A; Ljungvall I
Acta Vet Scand; 2020 Aug; 62(1):43. PubMed ID: 32758260
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease.
Moonarmart W; Boswood A; Luis Fuentes V; Brodbelt D; Souttar K; Elliott J
J Small Anim Pract; 2010 Feb; 51(2):84-96. PubMed ID: 20070494
[TBL] [Abstract][Full Text] [Related]
11. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
[TBL] [Abstract][Full Text] [Related]
12. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
13. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
14. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
Falk T; Ljungvall I; Zois NE; Höglund K; Olsen LH; Pedersen HD; Häggström J
J Vet Intern Med; 2013; 27(3):500-6. PubMed ID: 23551840
[TBL] [Abstract][Full Text] [Related]
16. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.
Hezzell MJ; Boswood A; Moonarmart W; Elliott J
J Vet Cardiol; 2012 Mar; 14(1):269-79. PubMed ID: 22366569
[TBL] [Abstract][Full Text] [Related]
17. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
[TBL] [Abstract][Full Text] [Related]
18. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
[TBL] [Abstract][Full Text] [Related]
19. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.
Zois NE; Olsen NT; Moesgaard SG; Rasmussen CE; Falk T; Häggström J; Pedersen HD; Møller JE; Olsen LH
J Vet Intern Med; 2013; 27(4):875-83. PubMed ID: 23731222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
